AbbVie | ABBV - Devedores Comerciais

Preço das Ações
205.07
Mudança Diária
-1.16 -0.56%
Mensal
-10.64%
Anual
-2.35%
Q1 Previsão
213.05




Devedores Comerciais Alterar Data
AbbVie USD 12.77B 132M 2025-09
Abbott USD 10.4B 166M 2025-09
ALKERMES USD 334.02M 21.08M 2025-12
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eisai JPY 249.06B 25B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
J&J USD 17.61B 235M 2025-09
Medtronic USD 6.36B 30M 2025-12
Merck USD 12.12B 596M 2025-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 100M 2025-12
UCB EUR 1.97B 54M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
United Therapeutics USD 350.2M 52.5M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Zoetis USD 1.59B 49M 2025-12